Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2006-11-21
2006-11-21
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
C514S885000
Reexamination Certificate
active
07138144
ABSTRACT:
A method of inducing tolerance to a transplant transplanted from a donor to a subject is disclosed. The method comprises (a) restricting outflow of a fluid from a portion of the circulatory system of the subject; and (b) administering a dose of bone marrow cells derived from the donor to a body part delimiting said portion of the circulatory system, prior to, concomitantly with or following transplantation of the transplant, thereby inducing tolerance to the transplant in the subject.
REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3839153 (1974-10-01), Schuurs et al.
patent: 3850578 (1974-11-01), McConnell
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3879262 (1975-04-01), Schuurs et al.
Askenasy “Localized Bone Marrow Transplantation Leads to Skin Allograft Acceptance in Nonmyeloablated Recipients: Comparison of Intra-Bone Marrow and Isolated Limb Perfusion”, Stem Cells, 20: 86-93, 2002.
Askenasy et al. “Cardiac Allograft Acceptance After Localized Bone Marrow Transplantation by Isolated Limb Perfusion in Nonmyeloablated Recipients”, Stem Cells, 21: 200-207, 2003.
Baba et al. “Intra-Bone Marrow-Bone Marrow Transplantation Facilitates Hemopoietic Recovery Including Dendritic Cells”, Immunobiology, 210: 33-42, 2005.
Bhatia et al. “Purification of Primitive Human Hematopoietic Cells Capable of Repopulating Immune-Deficient Mice”, Proc. Natl. Acad. Sci. USA, 94: 5320-5325, 1997.
Bonnet et al. “Cytokine Treatment or Accessory Cells Are Required to Initiate Engraftment of Purified Primitive Human Hematopoietic Cells Transplanted at Limiting Doses Into NOD/SCID Mice”, Bone Marrow Transplantation, 23: 203-209, 1999.
Burt et al. “Embryonic Stem Cells as An Alternative Marrow Donor Source: Engraftment Without Graft-Versus-Host Disease”, Journal of Experimental Medicine, 199(7): 895-904, 2004.
Castello et al. “Intra-Bone Marrow Injection of Bone Marrow and Cord Blood Cells: An Alternative Way of Transplantation Associated With a Higher Seedings Efficiency”, Experimental Hematology, 32: 782-787, 2004.
Chabner et al. “Direct Vascular Delivery of Primitive Hematopoietic Cells to Bone Marrow Improves Localization But Not Engraftment”, Blood, 103(12): 4685-4686, 2004.
Esumi et al. “Successful Allogeneic Leg Transplantation in Rats in Conjunction With Intra-Bone Marrow Injection of Donor Bone Marrow Cells”, Transplantation, 76(11): 1543-1548, 2003.
Fouillard et al. “Engraftment of Allogeneic Mesenchymal Stem Cells in the Bone Marrow of A Patient With Severe Idiopathic Aplastic Anemia Improves Stroma”, Leukemia, 17: 474-476, 2003.
Gandy et al. “Tolerance of Allogeneic Heart Grafts in Mice Simultaneously Reconstituted With Purified Allogeneic Hematopoietic Stem Cells”, Williams & Wilkins, 65(3): 295-304, 1998.
Gurevitch et al. “Reconstruction of Cartilage, Bone, and Hematopoietic Microenvironment With Demineralized Bone Matrix and Bone Marrow Cells”, Stem Cells, 21: 588-597, 2003.
Hägglund et al. “Intraosseous Compared to Intravenous Infusion of Allogeneic Bone Marrow”, Bone Marrow Transplantation, 21: 331-335, 1998.
Ikehara “New Strategies for BMT, Organ Transplantation, and Regeneration Therapy”, Hematology, 8(2): 2003.
Ikehara “A New Concept of Stem Cell Disorders and Their New Therapy”, Journal of Hematotherapy & Stem Cell Research, 12: 643-653, 2003.
Kaneda et al. “Long-Term Observation After Simultaneous Lung and Intra-Bone Marrow-Bone Marrow Transplantation”, The Journal of Heart and Lung Transplantation, 24: 1415-1423, 2005.
Bahia Kerbauy et al. “Engraftment of Distinct Clonal MDS-Derived Hematopoietic Precursors in NOD/SCID-β2-Microglobulin-Deficient Mice After Intramedullary Transplantation of Hematopoietic and Stromal Cells”, Blood, 104(7): 2202-2203, 2004.
Klicks et al. “Vascular Complications of Isolated Limb Perfusion”, European Journal of Surgical Oncology, 24: 288-291, 1998.
Kushida et al. “Treatment of Intractable Autoimmune Diseases in MRL/Lpr Mice Using A New Strategy for Allogeneic Bone Marrow Transplantation”, Blood, 95(5): 1862-1868, 2000.
Kushida et al. “Intra-Bone Marrow Injection of Allogeneic Bone Marrow Cells: A Powerful New Strategy for Treatment of Intractable Autoimmune Diseases in MRL/Lpr Mice”, Blood, 97(10): 3192-3299, 2001.
Mazurier et al. “Rapid Myeloerythroid Repopulation After Intrafemoral Transplantation of NOD-SCID Mice Reveals A New Class of Human Stem Cells”, Nature Medicine, 9(7): 959-963, 2003.
Nakamura et al. “Enhancement of Allogeneic Hematopoietic Stem Cell Engraftment and Prevention of GvHD by Intra-Bone Marrow Bone Marrow Transplantation Plus Donor Lymphocyte Infusion”, Stem Cells, 22: 125-134, 2004.
Reisner et al. “Transplantation Tolerance Induced by ‘Mega Dose’ CD34+ Cell Transplants”, Experimental Hematology, 28: 119-127, 2000.
Shizuru et al. “Purified Hematopoietic Stem Cell Grafts Induce Tolerance to Alloantigens and Can Mediate Positive and Negative T cell Selection”, Proc. Natl. Acad. Sci. USA, 97(17): 9555-9560, 2000.
Slavin et al. “Induction of Specific Tissue Transplantation Tolerance Using Fractionated Total Lymphoid Irradiation in Adult Mice: Long-Term Survival of Allogeneic Bone Marrow and Skin Grafts”, The Journal of Experimental Medicine, 146: 34-48, 1977.
Stam et al. “Systemic Toxicity and Cytokine/Acute Phase Protein Levels in Patients After Isolated Limb Perfusion With Tumor Necrosis Factor-α Complicated by High Leakage”, Annals of Surgical Oncology, 7(4): 268-275, 2000.
Stein et al. “Critical Early Events in Hematopoietic Cell Seeding and Engraftment”, Folia Histochemica et Cytobiologica, 43(4): 191-195, 2005.
Taira et al. “Treatment of Streptozotocin-Induced Diabetes Mellitus in Rats by Transplantation of Islet Cells From Two Major Histocompatibility Complex Disparate Rats in Combination With Intra Bone Marrow Injection of Allogeneic Bone Marrow Cells”, Transplantation, 79(6): 680-687, 2005.
Tominaga et al. “Current Techniques of Hyperthermic Isolated Limb Perfusion for Malignant Melanoma”, Surgery Today, 30: 339-342, 2000.
Uchida et al. “High Doses of Purified Stem Cells Cause Early Hematopoietic Recovery in Syngeneic and Allogeneic Hosts”, The Journal of Clinical Investigation, 101(5): 961-966, 1998.
Van Hennik et al. “Seeding Efficiency of Primitive Human Hematopoietic Cells in Nonobese Diabetic/Severe Combined Immune Deficiency Mice: Implications for Stem Cell Frequency Assessment”, Blood, 94(9): 3055-3061, 1999.
Verstegen et al. “Transplantation of Human Umbilical Cord Blood Cells in Macrophage-Depleted SCID Mice: Evidence for Accessory Cell Involvement in Expansion of Immature CD34+CD38- Cells”, Blood, 91(6): 1966-1976, 1998.
Vrouenraets et al. “Toxicity and Morbidity of Isolated Limb Perfusion”, Seminars in Surgical Oncology, 14: 224-231, 1998.
Wang et al. “SCID-Repopulating Cell Activity of Human Cord Blood-Derived CD34- Cells Assured by Intra-Bone Marrow Injection”, 101: 2924-2931, 2003.
Wright et al. “Physiological Migration of Hematopoietic Stem and Progenitor Cells”, Science, 294: 1933-1936, 2001.
Yahata et al. “A Highly Sensitive Strategy for SCID-Repopulating Cell Assay by Direct Injection of Primitive Human Hematopoietic Cells Into NOD/SCID Mice Bone Marrow”, Blood, 101(8): 2905-2913, 2003.
Zhang et al. “Simultaneous Injection of Bone Marrow Cells and Stromal Cells Into Bone Marrow Accelerates Hematopoiesis In Vivo”, Stem Cells, 22: 1256-1262, 2004.
Zhong et al. “Murine Hematopoietic Stem Cell Distribution and Proliferation in Ablated and Nonablated Bone Marrow
Belyavskyi Belyavskyi
Chan Christina
LandOfFree
Method of inducing immune tolerance via blood/lymph... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inducing immune tolerance via blood/lymph..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing immune tolerance via blood/lymph... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3697850